home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Courses and Workshops  
 

FDA's Vision for Interactions with Counterpart Regulators around the World

 
  November 15, 2007  
     
 
Drug Information Association, Online
Dec 10 2007


Understanding FDA’s New Approach to Protecting Public Health WEBINAR HIGHLIGHTS The discovery, development, manufacturing, authorization, marketing, and use of pharmaceutical products have gone global. As a result, FDA has changed its approach to protecting and promoting public health. This new approach recognizes borders as boundaries, rather than as barriers to illness, product movement, and knowledge. As such, FDA interactions with global regulators continue to grow. This webinar will discuss FDA’s vision for continued interactions with counterpart regulators and how these new interactions will affect future decisions.
 
 
Organized by: Drug Information Association
Invited Speakers: Murray M. Lumpkin, MDDeputy Commissioner (International and Special Programs)FDAUnited States.
 
Deadline for Abstracts: -
 
Registration: http://www.diahome.org/DIAHOME/Education/FindEducationalOffering.aspx?productID=15542&eventType=Webinar
E-mail: dia@diahome.org
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.